Literature DB >> 6332136

Detection of masked anti-DNA antibodies in lupus sera by a monoclonal anti-idiotype.

R Halpern, J Schiffenbauer, G Solomon, B Diamond.   

Abstract

We report here the use of a monoclonal anti-idiotype 3I to human anti-DNA antibodies to detect in serum idiotype-positive antigen-binding antibodies lacking DNA-binding activity as measured by conventional antigen binding assays. We studied paired serum samples from 13 patients with systemic lupus obtained at two times in the course of their disease: in each patient, one serum sample has anti-DNA activity and the second serum sample has no anti-dsDNA activity detectable by Millipore filter, ELISA, or Crithidia assay. Reactivity with 3I as detected with a radioimmunoassay (RIA) was present in all 13 sera with anti-dsDNA activity. Six patients showed a decrease in 3I reactivity to normal levels in the second serum sample, in which anti-dsDNA antibodies were not detectable by conventional antigen-binding assays. The other seven patients' second serum sample continued to show elevated 3I reactivity by RIA even though no anti-dsDNA activity was apparent. When the 3I-reactive antibodies from these latter patients' sera were eluted from a 3I affinity column, they revealed DNA-binding activity. Furthermore, dsDNA binding by these sera was apparent when they were displayed on Western blots of isoelectric focusing gels run in 8 M urea and incubated with radiolabeled dsDNA. These results indicate that the 3I anti-idiotype can detect anti-DNA antibodies in some sera of SLE patients that lack anti-DNA activity by ordinary assays. These antibodies may be inhibited in binding dsDNA by excess antigen or autologous anti-idiotype, and their DNA binding activity can be unmasked by procedures promoting immune complex dissociation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332136

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Isolation of a major protein component of Rosenthal fibers.

Authors:  J E Goldman; E Corbin
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

Review 2.  The idiotype-antiidiotype network in human autoimmunity.

Authors:  N I Abdou
Journal:  J Clin Immunol       Date:  1985-11       Impact factor: 8.317

3.  An in vitro assay for detection of glomerular binding IgG autoantibodies in patients with systemic lupus erythematosus.

Authors:  L Budhai; K Oh; A Davidson
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

4.  Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity.

Authors:  K Bhol; K Natarajan; N Nagarwalla; A Mohimen; V Aoki; A R Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

5.  Familial systemic lupus erythematosus. Presence of a cross-reactive idiotype in healthy family members.

Authors:  R Halpern; A Davidson; A Lazo; G Solomon; R Lahita; B Diamond
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  Expression in systemic lupus erythematosus of an idiotype common to DNA-binding and nonbinding monoclonal antibodies produced by normal human lymphoid cells.

Authors:  E Cairns; H Massicotte; D A Bell
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

7.  Distribution of anti-F(ab')2 antibodies and the 16/6 idiotype in systemic lupus erythematosus (SLE) probands and kindreds.

Authors:  F Silvestris; R A Searles; R C Williams; M A Rodriguez; R S Schwartz
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

8.  Lupus anti-DNA antibodies bearing the 8.12 idiotype appear to be somatically mutated.

Authors:  A Livneh; E Behar; A Many; M Ehrenfeld; E Gazit; B Diamond
Journal:  J Clin Immunol       Date:  1992-01       Impact factor: 8.317

Review 9.  Immunoblotting and dot blotting.

Authors:  D I Stott
Journal:  J Immunol Methods       Date:  1989-05-12       Impact factor: 2.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.